{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:05:29Z","timestamp":1792065929271,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e36735","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T23:27:30Z","timestamp":1725060450000},"page":"e36735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Application of a molecular networking approach using LC-HRMS combined with the MetWork webserver for clinical and forensic toxicology"],"prefix":"10.1016","volume":"10","author":[{"given":"Romain","family":"Magny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Beauxis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Genta-Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bourgogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e36735_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e36735_bib2","first-page":"2","article-title":"[Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects]","volume":"53","author":"Marquet","year":"1999","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.heliyon.2024.e36735_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fphar.2019.00265","article-title":"Risk of drug-drug interactions in out-hospital drug dispensings in France: results from the DRUG-drug interaction prevalence study","volume":"10","author":"Letinier","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pds.3592","article-title":"Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis","volume":"23","author":"Dechanont","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.heliyon.2024.e36735_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13814780701815116","article-title":"Risk factors for potential drug interactions in general practice","volume":"14","author":"Bjerrum","year":"2008","journal-title":"Eur. J. Gen. Pract."},{"key":"10.1016\/j.heliyon.2024.e36735_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/bcp.13471","article-title":"Drug-related deaths in hospital inpatients: a retrospective cohort study","volume":"84","author":"Montane","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib7","first-page":"55","article-title":"The laboratory's role in opioid pain medication monitoring","volume":"23","author":"Bodor","year":"2012","journal-title":"Ejifcc"},{"key":"10.1016\/j.heliyon.2024.e36735_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mas.10050","article-title":"Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry","volume":"22","author":"Hopfgartner","year":"2003","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.heliyon.2024.e36735_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00216-007-1320-1","article-title":"Current role of LC-MS in therapeutic drug monitoring","volume":"388","author":"Saint-Marcoux","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.heliyon.2024.e36735_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpba.2014.09.030","article-title":"Generic on-line solid phase extraction sample preparation strategies for the analysis of drugs in biological matrices by LC-MS\/MS","volume":"102","author":"Bourgogne","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e36735_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1515\/cclm-2019-0820","article-title":"Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives","volume":"58","author":"Tanna","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.heliyon.2024.e36735_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1373\/clinchem.2015.248146","article-title":"Effective use of mass spectrometry in the clinical laboratory","volume":"62","author":"Jannetto","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.heliyon.2024.e36735_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00007691-200204000-00008","article-title":"Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology","volume":"24","author":"Marquet","year":"2002","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.heliyon.2024.e36735_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-61779-934-1_2","article-title":"LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays","volume":"902","author":"Marquet","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4155\/bio.13.81","article-title":"High-resolution MS in regulated bioanalysis: where are we now and where do we go from here?","volume":"5","author":"Fung","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.heliyon.2024.e36735_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chroma.2012.08.069","article-title":"What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?","volume":"1292","author":"Maurer","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.heliyon.2024.e36735_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","author":"Wu","year":"2012","journal-title":"Clin Toxicol Phila"},{"key":"10.1016\/j.heliyon.2024.e36735_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/mas.21401","article-title":"High resolution mass spectrometry based techniques at the crossroads of metabolic pathways","volume":"33","author":"Junot","year":"2014","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.heliyon.2024.e36735_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/metabo10060225","article-title":"Lipid annotation by combination of UHPLC-HRMS (MS), molecular networking, and retention time prediction: application to a lipidomic study of in vitro models of dry eye disease","volume":"10","author":"Magny","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.heliyon.2024.e36735_bib20","article-title":"Advances in high-resolution mass spectrometry techniques for analysis of high mass-to-charge ions","author":"Lai","year":"2022","journal-title":"Mass Spectrom. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e36735_bib21","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1093\/toxsci\/kfq358","article-title":"Metabolomics in toxicology: preclinical and clinical applications","volume":"120","author":"Robertson","year":"2011","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/14737175.2016.1182022","article-title":"Precision medicine for psychopharmacology: a general introduction","volume":"16","author":"Shin","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.heliyon.2024.e36735_bib23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nbt.3597","article-title":"Sharing and community curation of mass spectrometry data with global natural products social molecular networking","volume":"34","author":"Wang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/dta.2550","article-title":"Application of a molecular networking approach for clinical and forensic toxicology exemplified in three cases involving 3-MeO-PCP, doxylamine, and chlormequat","volume":"11","author":"Allard","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.heliyon.2024.e36735_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/metabo12070665","article-title":"Molecular network-based identification of tramadol metabolites in a fatal tramadol poisoning","volume":"12","author":"Magny","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.heliyon.2024.e36735_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.572952","article-title":"Molecular networking: a useful tool for the identification of new psychoactive substances in seizures by LC\u2013HRMS","volume":"8","author":"Vincenti","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2024.e36735_bib27","unstructured":"Article L1245-2 - Code de la sant\u00e9 publique - L\u00e9gifrance, (n.d.). https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000006686256\/2004-08-07 (accessed February 2, 2021)."},{"key":"10.1016\/j.heliyon.2024.e36735_bib28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/1471-2105-11-395","article-title":"MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data","volume":"11","author":"Pluskal","year":"2010","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2024.e36735_bib30","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1021\/acs.analchem.7b00947","article-title":"One step forward for reducing false positive and false negative compound identifications from mass spectrometry metabolomics data: new algorithms for constructing extracted ion chromatograms and detecting chromatographic peaks","volume":"89","author":"Myers","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.heliyon.2024.e36735_bib31","doi-asserted-by":"crossref","DOI":"10.1021\/acs.analchem.8b03099","article-title":"MetGem software for the generation of molecular networks based on the t-SNE algorithm","author":"Olivon","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.heliyon.2024.e36735_bib32","doi-asserted-by":"crossref","first-page":"W94","DOI":"10.1093\/nar\/gku436","article-title":"CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra","volume":"42","author":"Allen","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e36735_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9040072","article-title":"CFM-ID 3.0: significantly improved ESI-MS\/MS prediction and compound identification","volume":"9","author":"Djoumbou-Feunang","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.heliyon.2024.e36735_bib34","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/bioinformatics\/bty864","article-title":"MetWork: a web server for natural products anticipation","volume":"35","author":"Beauxis","year":"2019","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.heliyon.2024.e36735_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006089","article-title":"Propagating annotations of molecular networks using in silico fragmentation","volume":"14","author":"da Silva","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1044-0305(01)00327-0","article-title":"Comparing similar spectra: from similarity index to spectral contrast angle","volume":"13","author":"Wan","year":"2002","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.heliyon.2024.e36735_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.drudis.2012.01.017","article-title":"Reactions and enzymes in the metabolism of drugs and other xenobiotics","volume":"17","author":"Testa","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2024.e36735_bib38","unstructured":"."},{"key":"10.1016\/j.heliyon.2024.e36735_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/md17060319","article-title":"Bromotryptamine and bromotyramine derivatives from the tropical southwestern pacific sponge narrabeena nigra","volume":"17","author":"Miguel-Gordo","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.heliyon.2024.e36735_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0773.1989.tb01123.x","article-title":"Glucuronidation of amitriptyline in man in vivo","volume":"65","author":"Dahl-Puustinen","year":"1989","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e36735_bib41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00216-010-3636-5","article-title":"Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry","volume":"397","author":"Meyer","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.heliyon.2024.e36735_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/dmd.114.061416","article-title":"Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate","volume":"43","author":"Pozo","year":"2015","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.heliyon.2024.e36735_bib43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jat\/bkx111","article-title":"Diagnosis of heroin overdose in an 8-year-old boy: reliable contribution of toxicological investigations","volume":"42","author":"Soichot","year":"2018","journal-title":"J. Anal. Toxicol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024127661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024127661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:15:11Z","timestamp":1790543711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024127661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":43,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024127661"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36735","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of a molecular networking approach using LC-HRMS combined with the MetWork webserver for clinical and forensic toxicology","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e36735"}}